Site-directed polyethylene glycol modification of trichosanthin: Effects on its biological activites, pharmacokinetics, and antigenicity

This publication has 34 references indexed in Scilit:

• A Phase II Study of Effect of Addition of Trichosanthin to Zidovudine in Patients with HIV Disease and Failing Antiretroviral Agents
  AIDS Research and Human Retroviruses, 1994
• Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex
  Antimicrobial Agents and Chemotherapy, 1994
• Minireview: Trichosanthin - a protein with multiple pharmacological properties
  Life Sciences, 1994
• The mechanism of action of trichosanthin on eukaryotic ribosomes—RNA N-glycosidase activity of the cytotoxin
  Nucleic Acids Research, 1992
• Trichosanthin treatment of HIV-induced immune dysregulation
  European Journal of Clinical Investigation, 1992
• Increasing the plasma half-life of trichosanthin by coupling to dextran
  Biochemical Pharmacology, 1991
• The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex
  AIDS, 1990
• A phase I/II study of trichosanthin treatment of HIV disease
  AIDS, 1990
• Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines
  Toxicon, 1990
• Trichosanthin, α‐momorcharin and β‐momorcharin: identity of abortifacient and ribosome‐inactivating proteins
  International Journal of Peptide and Protein Research, 1988